Pj. Lupardus et al., Membrane-delimited coupling between sigma receptors and K+ channels in ratneurohypophysial terminals requires neither G-protein nor ATP, J PHYSL LON, 526(3), 2000, pp. 527-539
1. Receptor-mediated modulation of ion channels generally involves G-protei
ns, phosphorylation, or both in combination. The sigma receptor, which modu
lates voltage-gated K+ channels, is a novel protein with no homology to oth
er receptors known to modulate ion channels. In the present study patch cla
mp and photolabelling techniques were used to investigate the mechanism by
which sigma receptors modulate K+ channels in peptidergic nerve terminals.
2. The sigma receptor photoprobe iodoazidococaine labelled a protein with t
he same molecular mass (26 kDa) as the sigma receptor protein identified by
cloning.
3. The sigma receptor ligands pentazocine and SKF10047 modulated K+ channel
s, despite intra-terminal perfusion with GTP-free solutions, a Gi-protein i
nhibitor (GDP beta S), a G-protein activator (GTP gamma S) or a non-hydroly
sable ATP analogue (AMPPcP).
4. Channels in excised outside-out patches were modulated by ligand, indica
ting that soluble cytoplasmic factors are not required. In contrast, channe
ls within cell-attached patches were not modulated by ligand outside a patc
h, indicating that receptors and channels must be in close proximity for fu
nctional interactions. Channels expressed in oocytes without receptors were
unresponsive to sigma receptor agonists, ruling out inhibition through a d
irect drug interaction with channels.
5. These experiments indicate that sigma receptor-mediated signal transduct
ion is membrane delimited, and requires neither G-protein activation nor pr
otein phosphorylation. This novel transduction mechanism is mediated by mem
brane proteins in close proximity, possibly through direct interactions bet
ween the receptor and channel. This would allow for more rapid signal trans
duction than other ion channel modulation mechanisms, which in the present
case of neurohypophysial nerve terminals would lead to the enhancement of n
europeptide release.